Skip to main content
. 2014 Sep 10;37(10):2668–2676. doi: 10.2337/dc14-0817

Figure 3.

Figure 3

Cumulative diabetes incidence in the U.S. DPP study, showing subjects with prediabetes who were given troglitazone or placebo, including time points before and after the primary study was stopped (vertical dashed line). Adapted with permission from Knowler et al. (33).